tiprankstipranks
MyMD Pharmaceuticals announces 1-for-30 reverse stock split
PremiumThe FlyMyMD Pharmaceuticals announces 1-for-30 reverse stock split
2M ago
MyMD Pharmaceuticals announces results from Supera-CBD study
PremiumThe Fly
MyMD Pharmaceuticals announces results from Supera-CBD study
6M ago
MyMD Pharma to present  ‘statistically’ significant Phase 2 data for MYMD-1
PremiumThe Fly
MyMD Pharma to present ‘statistically’ significant Phase 2 data for MYMD-1
7M ago
MyMD Pharmaceuticals gives dosing update on Phase 2 of MYMD-1 trial
PremiumThe FlyMyMD Pharmaceuticals gives dosing update on Phase 2 of MYMD-1 trial
1y ago
MyMD Pharmaceuticals presents data from MYMD-1 preclinical study
PremiumThe Fly
MyMD Pharmaceuticals presents data from MYMD-1 preclinical study
1y ago
MyMD Pharmaceuticals: DEA determines Supera-CBD not a controlled substance
PremiumThe Fly
MyMD Pharmaceuticals: DEA determines Supera-CBD not a controlled substance
1y ago
MyMD Pharmaceuticals announces $15M offering with existing investors
PremiumThe FlyMyMD Pharmaceuticals announces $15M offering with existing investors
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100